Announcements Trials

Browse Landscape

Status

Completed 164 Recruiting 47 Terminated 37 Active not recruiting 31 Unknown 17 Not yet recruiting 8 Withdrawn 6 Approved for marketing 4 Enrolling by invitation 2 Suspended 1 No longer available 1 Available 1

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Lymphoid 12 Thoracic 9 Genitourinary 9 Gastrointestinal 9 Sarcoma 8 Other hematologic neoplasm 8 CNS 8 Tumor-Agnostic 7 Plasma cell 5 Myeloid 5 Dermatologic 5 Breast 5 Gynecologic 4 Other solid neoplasm 2 Head & Neck 2 Endocrine 1

Conditions

Pheochromocytoma 1 Paraganglioma 1 Neuroblastoma 1

Interventions

3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Available × INDUSTRY × Endocrine × Clear all

NCT01590680 2023-02-28

Expanded Access Protocol Using 131I-MIBG

Jubilant DraxImage Inc.

Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡